Alinity m reagents and supplies
Ended Awarded Last action
- Contract number
- 36C25922N0116
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$832
Award facts
- Opportunity
-
- 36C25922Q0062 Solicitation number
- Contract value 0% obligated
-
- $282,198.88 Current, with exercised options
- $1,313,443.20 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$832 | |
| Supplemental Agreement for work within scope | $25,219 | |
| Original award | $257,811 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a $1.31M firm fixed-price Blanket Purchase Agreement (BPA) call for Alinity M reagents and supplies by Veterans Integrated Service Network 19 on December 1, 2021, with completion scheduled for November 30, 2022. The contract, issued under the General Services Administration's In-Vitro Diagnostics, Reagents, Test schedule (FSS-65-VII), supports molecular diagnostic testing operations at the VA facility in Aurora, Colorado. Abbott Molecular specializes in advanced molecular diagnostic equipment and consumables, including reagents for infectious disease screening, COVID-19, HIV, hepatitis C, and human papillomavirus testing. This award carries no small business set-aside designation, consistent with Abbott's status as a large, established medical technology corporation with an extensive federal contract portfolio.
The BPA call represents one of several task orders issued under Abbott Molecular's larger $3.2M blanket purchase agreement with VISN 19 for Alinity M reagents and supplies, with associated orders ranging from $350,000 to $2.76M issued between December 2021 and December 2025. Abbott Laboratories and its subsidiary maintain significant indefinite delivery vehicles across multiple Veterans Integrated Service Networks and federal healthcare agencies, including the Department of Defense, Centers for Disease Control and Prevention, and Indian Health Service, positioning the company as a critical supplier within the federal government's molecular diagnostics infrastructure and pandemic response capabilities.
Quick answers
Who was awarded contract 36C25922N0116?
36C25922N0116 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on December 1, 2021.
How much is contract 36C25922N0116 worth?
The government has obligated -$832 on 36C25922N0116. Its current value, with exercised options, is $282,199. Its potential value, with all options, is $1,313,443.
Is contract 36C25922N0116 an order under another contract?
Yes. 36C25922N0116 is a BPA call under V797D40222-36C25922A0005, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25922N0116 competed?
The extent of competition for 36C25922N0116 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award